PRG-3, or Plasticity-related gene 3, is a member of the lipid phosphate phosphatase-related protein family and is known primarily for its involvement in neuronal growth and the modulation of synaptic plasticity. PRG-3 is expressed in various parts of the nervous system, where it facilitates neurite outgrowth and branching by modifying the local lipid environment. This modification is critical for the formation and retraction of neuronal processes, which are key for brain development and the adaptation of neural circuits in response to learning and memory. PRG-3 is thought to influence the levels of bioactive lipids at the plasma membrane, which play significant roles in signaling pathways that control cytoskeletal dynamics and cell adhesion. Through its actions, PRG-3 contributes to the structural and functional plasticity of neurons, making it an important player in the regulation of neural connectivity and brain function.
The activation of PRG-3 is intricately linked to its role in lipid signaling within neuronal cells. It operates primarily by modulating the concentration of phosphatidic acid (PA) and lysophosphatidic acid (LPA), two lipids involved in the signaling pathways that govern neurite outgrowth and synaptic activity. PRG-3's enzymatic activity allows it to dephosphorylate PA and LPA, reducing their levels and thereby influencing downstream signaling events that control cytoskeletal rearrangement and membrane dynamics. The expression and activity of PRG-3 are regulated by neuronal activity and developmental cues, which ensure that its function is closely matched to the physiological needs of the neuron. Additionally, post-translational modifications, such as phosphorylation, may regulate the activity and stability of PRG-3, affecting its ability to interact with membrane lipids and other proteins involved in neuronal signaling pathways. This regulation of PRG-3 activity ensures that neurons can dynamically adapt their morphology and connectivity in response to environmental and developmental changes, highlighting the protein's crucial role in neural development and cognitive functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $39.00 $75.00 | 9 | |
Activates purinergic receptors involved in granulocyte activation. This can modulate PRG3 function indirectly. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
A direct precursor in the histamine biosynthetic process, thereby affecting PRG3 function in granulocytes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels, affecting PKA and CREB, which can in turn regulate gene expression affecting PRG3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, impacting granulocyte activation processes that can indirectly influence PRG3. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can influence metalloproteinases, impacting the remodeling of extracellular matrix and PRG3. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
HDAC inhibitor that can affect gene expression regulation, thereby affecting PRG3 activity. | ||||||
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $31.00 $61.00 $219.00 $352.00 | 2 | |
Precursor for NO synthesis, affecting granulocyte activation and thus PRG3 indirectly. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor that affects various signaling pathways, possibly affecting PRG3 through gene regulation. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Affects a variety of kinases and signaling pathways, indirectly affecting PRG3 through gene expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Affects SIRT1 and AMPK pathways, which can have a downstream impact on PRG3 regulation. | ||||||